Analysis of hydrophobic interactions of antagonists with the beta2-adrenergic receptor

SAR and QSAR in Environmental Research

Volumn 21, Issue 1-2, 2010, Pages 37-55

  Novoseletsky, V N ^a   Pyrkov, T V ^a   Efremov, R G ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

Beta adrenoceptor; G protein coupled receptors; Molecular hydrophobicity potential; Protein ligand interactions

Indexed keywords

CRYSTAL STRUCTURE; DISSOCIATION; HYDROPHOBICITY; PHYSIOLOGICAL MODELS; PROTEINS;

ADRENERGIC RECEPTORS; BETA-ADRENOCEPTOR; BETA-BLOCKERS; G PROTEIN COUPLED RECEPTORS; HYDROPHOBIC EFFECT; HYDROPHOBIC INTERACTIONS; MOLECULAR FRAGMENTS; MOLECULAR HYDROPHOBICITY; MOLECULAR HYDROPHOBICITY POTENTIAL; PROTEIN-LIGAND INTERACTIONS;

LIGANDS;

EID: 77951434707     PISSN: 1062936X     EISSN: 1029046X     Source Type: Journal    
DOI: 10.1080/10629360903560637     Document Type: Article

References (48)

1. R. Fredriksson and H.B. Schioth, The repertoire of G-protein-coupled receptors in fully sequenced genomes, Mol. Pharmacol. 67 (2005), pp. 1414-1425.
2. D.S. Wishart, C. Knox, A.C. Guo, D. Cheng, S. Shrivastava, D. Tzur, B. Gautam, and M. Hassanali, DrugBank: A knowledge base for drugs drug actions and drug targets, Nucleic Acids Res. 36 (2008), pp. D901-906.
3. V. Cherezov, D.M. Rosenbaum, M.A. Hanson, S.G. Rasmussen, F.S. Thian, T.S. Kobilka, H.J. Choi, P. Kuhn, W.I Weis, B.K. Kobilka, and R.C. Stevens, High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor, Science 318 (2007), pp. 1258-1265.
4. S.G. Rasmussen, H.J. Choi, D.M. Rosenbaum, T.S. Kobilka, F.S. Thian, P.C. Edwards, M. Burghammer, V.R. Ratnala, R. Sanishvili, R.F. Fischetti, G.F. Schertler, W.I. Weis, and B.K. Kobilka, Crystal structure of the human beta2 adrenergic G-protein-coupled receptor, Nature 450 (2007), pp. 383-387.
5. M.A. Hanson, V. Cherezov, M.T. Griffith, C.B. Roth, V.P. Jaakola, E.Y. Chien, J. Velasquez, P. Kuhn, and R.C. Stevens, A specific cholesterol binding site is established by the 2.8A structure of the human beta2-adrenergic receptor, Structure 16 (2008), pp. 897-905.
6. A.M. Lands, A. Arnold, J.P. MacAuliff, and T.G. Brown, Differentiation of receptor systems activated by sympathomimetic amines, Nature 214 (1967), pp. 597-598.
7. G.A. Weiland, K.P. Minneman, and P.B. Molinoff, Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor, Nature 281 (1979), pp. 114-117.
8. F. Bree, N. el Tayar, H. Van de Waterbeemd, B. Testa, and J.P. Tillement, The binding of agonists and antagonists to rat lung beta-adrenergic receptors as investigated by thermodynamics and structure-activity relationships, J. Recept. Res. 6 (1986), pp. 381-409.
9. M.L. Contreras, B.B. Wolfe, and P.B. Molinoff, Thermodynamic properties of agonist interactions with the beta-adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta-adrenergic receptors, J. Pharmacol. Exp. Ther. 237 (1986), pp. 154-164.
10. M.L. Contreras, B.B. Wolfe, and P.B. Molinoff, Thermodynamic properties of agonist interactions with the beta-adrenergic receptor-coupled adenylate cyclase system. II. Agonist binding to soluble beta-adrenergic receptors, J. Pharmacol. Exp. Ther. 237 (1986), pp. 165-172.
11. H. van de Waterbeemd, D.A. Smith, and B.C. Jones, Lipophilicity in PK design: Methyl, ethyl, futile, J. Comput.-Aided Mol. Des. 15 (2001), pp. 273-286.
12. R. Mannhold, The impact of lipophilicity in drug research: A case report on beta-blockers, Mini Rev. Med. Chem. 5 (2005), pp. 197-205.
13. L. Rivail, M. Giner, M. Gastineau, M. Berthouze, J.L. Soulier, R. Fischmeister, F. Lezoualc'h, B. Maigret, S. Sicsic, and I. Berque-Bestel, New insights into the human 5-HT4 receptor binding site: Exploration of a hydrophobic pocket, Br. J. Pharmacol. 143 (2004), pp. 361-370.
14. J. Varady, X. Wu, X. Fang, J. Min, Z. Hu, B. Levant, and S. Wang, Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: Discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach, J. Med. Chem. 46 (2003), pp. 4377-4392.
15. B. Testa, P.A. Carrupt, P. Gaillard, F. Billois, and P. Weber, Lipophilicity in molecular modeling, Pharm. Res. 13 (1996), pp. 335-343.
16. H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov, and P.E. Bourne, The protein data bank, Nucleic Acid Res. 28 (2000), pp. 235-242.
17. G. Jones, P. Willett, R.C. Glen, A.R. Leach, and R.D. Taylor, Development and validation of a genetic algorithm for flexible docking, J. Mol. Biol. 267 (1997), pp. 727-748.
18. MacroModel, version 9.5. Schrödinger, LLC, New York, NY, 2007; software available at http:// www.schrodinger.com
19. C.D. Strader, I.S. Sigal, M.R. Candelore, E. Rands, W.S. Hill, and R.A. Dixon, Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function, J. Biol. Chem. 263 (1988), pp. 10267-10271.
20. H.M. Zuurmond, J. Hessling, K. Bluml, M. Lohse, and A.P. Ijzerman, Study of interaction between agonists and asn293 in helix VI of human beta(2)-adrenergic receptor, Mol. Pharmacol. 56 (1999), pp. 909-916.
21. B.K. Kobilka, G protein coupled receptor structure and activation, Biochim. Biophys. Acta. 1768(2007), pp.794-807.
22. M.D. Eldridge, C.W. Murray, T.R. Auton, G.V. Paolini, and R.P. Mee, Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes, J. Comp.-Aided Molec. Des. 11 (1997), pp. 425-445.
23. Glide, version 4.5. Schrodinger, LLC, New York, NY, 2007; software available at http:// www.schrodinger.com
24. P. Gaillard, P.A. Carrupt, B. Testa, and A. Boudon, Molecular lipophilicity potential, a tool in 3D QSAR: Method and applications, J. Comput.-Aided Mol. Des. 8 (1994), pp. 83-96.
25. R.G. Efremov, A.O. Chugunov, T.V. Pyrkov, J.P. Priestle, A.S. Arseniev, and E. Jacoby, Molecular lipophilicity in protein modeling and drug design, Curr. Med. Chem. 14 (2007), pp. 393-415.
26. A.K. Ghose, V.N. Viswanadhan, and J.J. Wendoloski, Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: An analysis of ALOGP and CLOGP methods, J. Phys. Chem. 102 (1998), pp. 3762-3772.
27. M.L. Connolly, Solvent-accessible surfaces of proteins and nucleic acids, Science 221 (1983), pp. 709-713.
28. T.V. Pyrkov, A.O. Chugunov, N.A. Krylov, D.E. Nolde, and R.G. Efremov, PLATINUM: A web tool for analysis of hydrophobic/hydrophilic organization of biomolecular complexes, Bioinformatics 25 (2009), pp. 1201-1202.
29. T.V. Pyrkov and R.G. Efremov, A fragment-based scoring function to re-rank ATP docking results, Int. J. Mol. Sci. 8 (2007), pp. 1083-1094.
30. E.M. Brown, S.A. Fedak, C.J. Woodard, and G.D. Aurbach, Beta-Adrenergic receptor interactions. Direct comparison of receptor interaction and biological activity, J. Biol. Chem. 251 (1976), pp. 1239-1246.
31. A.S. Manalan, H.R. Besch Jr, and A.M. Watanabe, Characterization of [3H](+/-) carazolol binding to beta-adrenergic receptors, Circ. Res. 49 (1981), pp. 326-336.
32. A.P. Ijzerman, G.H. Aue, T. Bultsma, M.R. Linschoten, and H. Timmerman, Quantitative evaluation of the beta 2-adrenoceptor affinity of phenoxypropanolamines and phenylethanolamines, J. Med. Chem. 28 (1985), pp. 1328-1334.
33. R. Del Carmine, C. Ambrosio, M. Sbraccia, S. Cotecchia, A.P. Ijzerman, and T. Costa, Mutations inducing divergent shifts of constitutive activity reveal different modes of binding among catecholamine analogues to the beta(2)-adrenergic receptor, Br. J. Pharmacol. 135 (2002), pp. 1715-1722.
34. J.G. Baker, The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors, Br. J. Pharmacol. 144 (2005), pp. 317-322.
35. P. Kolb, D.M. Rosenbaum, J.J. Irwin, J.J. Fung, B.K. Kobilka, and B.K. Shoichet, Structure-based discovery of beta2-adrenergic receptor ligands, Proc. Natl. Acad. Sci. USA 106 (2009), pp. 6843-6848.
36. V. Katritch, K.A. Reynolds, V. Cherezov, M.A. Hanson, C.B. Roth, M. Yeager, and R. Abagyan, Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes, J. Mol. Recognit. 22 (2009), pp. 307-318.
37. S. Suryanarayana and B.K. Kobilka, Amino acid substitutions at position 312 in the seventh hydrophobic segment of the beta 2-adrenergic receptor modify ligand-binding specificity, Mol. Pharmacol. 44 (1993), pp. 111-114.
38. S. Bhattacharya, S.E. Hal, H. Li, and N. Vaidehi, Ligand-stabilized conformational states of human beta(2) adrenergic receptor: Insight into G-protein-coupled receptor activation, Biophys. J. 94 (2008), pp. 2027-2042.
39. C.D. Strader, I.S. Sigal, and R.A. Dixon, Structural basis of beta-adrenergic receptor function, FASEB J. 3 (1989), pp. 1825-1832.
40. Maestro, version 8.0. Schrodinger, LLC, New York, NY, 2007; software available at http:// www.schrodinger.com
41. K.A. Reynolds, V. Katritch, and R. Abagyan, Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators, J. Comput.-Aided Mol. Des. 23 (2009), pp. 273-288.
42. G. Jones, P. Willett, and R.C. Glen, Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation, J. Mol. Biol. 245 (1995), pp. 43-53.
43. M.D. Eldridge, C.W. Murray, T.R. Auton, G.V. Paolin, and R.P Mee, Empirical scoring functions: Part 1, the development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes, J. Comput.-Aided Mol. Des. 11 (1997), pp. 425-445.
44. J.L. Banks, H.S. Beard, Y. Cao, A.E. Cho, W. Damm, R. Farid, A.K. Felts, T.A. Halgren, D.T. Mainz, J.R. Maple, R. Murphy, D.M. Philipp, M.P. Repasky, L.Y. Zhang, B.J. Berne, R.A. Friesner, E. Gallicchio, and R.M. Levy, Integrated modeling program, applied chemical theory (IMPACT), J. Comput. Chem. 26 (2005), pp. 1752-1780.
45. CombiGlide, version 1.5. Schrodinger, LLC, New York, NY, 2007; software available at http:// www.schrodinger.com
46. T. Warne, M.J. Serrano-Vega, J.G. Baker, R. Moukhametzianov, P.C. Edwards, R. Henderson, A.G. Leslie, C.G. Tate, and G.F. Schertler, Structure of a beta1-adrenergic G-protein-coupled receptor, Nature 454 (2003), pp. 486-491.
47. S.N. Louis, L.A. Rezmann-Vitti, T.L. Nero, D. Iakovidis, G.P. Jackman, and W.J. Louis, CoMFA analysis of the human beta(1)-adrenoceptor binding affinity of a series of phenoxypropanolamines, Eur. J. Med. Chem. 37 (2002), pp. 111-125.
48. N. el Tayar, B. Testa, H. van de Waterbeemd, P.A. Carrupt, and A.J. Kaumann, Influence of lipophilicity and chirality on the selectivity of ligands for beta 1- and beta 2-adrenoceptors, J. Pharm. Pharmacol. 40 (1988), pp. 609-612.